AUTH/2381/1/11 – Director/Merz Pharma v Allergan (Alleged breach of undertaking)

📅 2011 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2381/1/11
PartiesDirector/Merz Pharma v Allergan
IssueAlleged breach of undertaking
Complaint received12 January 2011
Completed18 March 2011
Applicable Code year2011
BreachNo breach, outwith the scope of the Code
AppealNo appeal
Sanctions appliedUndertaking received
Additional sanctionsNot stated
Case reportNo case report as outwith the scope of the Code

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A complaint was made by the Director/Merz Pharma against Allergan.
  • The allegation related to an alleged breach of an undertaking.
  • The complaint was received on 12 January 2011.
⚖️

Outcome

  • No breach – the matter was outwith the scope of the Code.
  • No appeal.
  • No case report was published because it was outwith the scope of the Code.
  • Case completed on 18 March 2011.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training